Expand Energy vs Occidental Petroleum
EXE and OXY side by side, both in crude petroleum and natural gas. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EXE and OXY compare
Occidental Petroleum is the larger company, worth 2.8 times as much as Expand Energy ($57.2B against $20.5B).
On earnings, Expand Energy is cheaper: it trades at 7.7× trailing earnings, against 7.7× for Occidental Petroleum.
Occidental Petroleum grew revenue faster over the last twelve months (34.7% versus 28.2% for Expand Energy).
Both pay dividends: Expand Energy yields 3.2% and Occidental Petroleum 1.8%.
Expand Energy scores higher on the StockData Score (16 against 11 for Occidental Petroleum), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EXE | OXY |
|---|---|---|
| Size and price | ||
| Market cap | $20.5B | $57.2B |
| Share price | $88.63 | $57.24 |
| Change, 1 year | −22.8% | 36.9% |
| Change, 5 years | 43.6% | 96.6% |
| Beta (5Y) | 0.60 | 0.42 |
| Employees | 1,600 | 6,793 |
| StockData Score | ||
| Total score | 16 (better) | 11 |
| Valuation score | 5 | 5 |
| Growth score | 1 | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 3 | 4 (better) |
| Dividend score | 3 (better) | 1 |
| Valuation | ||
| P/E | 7.7× (better) | 7.7× |
| P/S | 1.5× (better) | 2.3× |
| P/B | 1.0× (better) | 1.3× |
| EV/EBITDA | 3.8× (better) | 4.5× |
| P/FCF | 7.9× (better) | 9.8× |
| FCF yield | 12.7% (better) | 10.3% |
| Fair value | $100.71 | $78.43 |
| Margin of safety | 12.0% | 27.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 28.2% | 34.7% (better) |
| Revenue growth, 5Y average | 18.3% (better) | 3.9% |
| Net income growth (TTM) | 218% | – |
| EPS growth (TTM) | 228% | 438% (better) |
| Profitability | ||
| Operating margin | 25.7% | – |
| Net margin | 19.8% | – |
| FCF margin | 18.6% | 23.5% (better) |
| Return on equity | 14.6% | – |
| Return on invested capital | 12.2% | – |
| Financial health | ||
| Debt / equity | 0.24 (better) | 0.27 |
| Net debt / EBITDA | 0.69 | 0.55 (better) |
| Interest coverage | 17.4× | – |
| Current ratio | 0.90 | 1.38 (better) |
| Altman Z-score | 2.32 (better) | 1.82 |
| Piotroski F-score | 7 | – |
| Dividends and buybacks | ||
| Dividend yield | 3.2% (better) | 1.8% |
| Payout ratio | 19.9% | – |
| Years of dividend growth | – | 4 |
| Dividend growth, 5Y average | – | 3.2% |
| Buyback yield | 4.4% (better) | −0.25% |
| Shareholder yield | 7.6% (better) | 1.6% |
| Ownership | ||
| Held by institutions | 95.5% | 83.6% |
| Held by insiders | 0.33% | 0.39% |
| Insider net buying, 12 months | $877K (better) | $445K |
| Superinvestors holding | 1 | 2 (better) |
| Short interest, % of float | 5.1% | 2.7% |
Go deeper
- EXE stock overview
- EXE income statement
- EXE valuation and score
- OXY stock overview
- OXY income statement
- OXY valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.